Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 1
2017 4
2018 2
2019 2
2020 2
2021 5
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Fortunato O, Huber V, Segale M, Cova A, Vallacchi V, Squarcina P, Rivoltini L, Suatoni P, Sozzi G, Pastorino U, Boeri M. Fortunato O, et al. Among authors: suatoni p. Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2020-2029. doi: 10.1158/1055-9965.EPI-22-0689. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36112827 Free PMC article.
Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.
Pastorino U, Ladisa V, Trussardo S, Sabia F, Rolli L, Valsecchi C, Ledda RE, Milanese G, Suatoni P, Boeri M, Sozzi G, Marchianò A, Munarini E, Boffi R, Gallus S, Apolone G. Pastorino U, et al. Among authors: suatoni p. J Thorac Oncol. 2022 Nov;17(11):1276-1286. doi: 10.1016/j.jtho.2022.07.007. Epub 2022 Jul 28. J Thorac Oncol. 2022. PMID: 35908731 Free article. Clinical Trial.
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
Vismara M, Reduzzi C, Silvestri M, Murianni F, Lo Russo G, Fortunato O, Motta R, Lanzoni D, Giovinazzo F, Miodini P, Pasquali S, Suatoni P, Pastorino U, Roz L, Sozzi G, Cappelletti V, Bertolini G. Vismara M, et al. Among authors: suatoni p. Clin Chem. 2022 May 18;68(5):691-701. doi: 10.1093/clinchem/hvac019. Clin Chem. 2022. PMID: 35304611
Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320.
Pontis F, Roz L, Mensah M, Segale M, Moro M, Bertolini G, Petraroia I, Centonze G, Ferretti AM, Suatoni P, Pastorino U, Fortunato O, Sozzi G. Pontis F, et al. Among authors: suatoni p. J Exp Clin Cancer Res. 2021 Jul 21;40(1):237. doi: 10.1186/s13046-021-02040-3. J Exp Clin Cancer Res. 2021. PMID: 34289890 Free PMC article.
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling.
Di Paolo D, Pontis F, Moro M, Centonze G, Bertolini G, Milione M, Mensah M, Segale M, Petraroia I, Borzi C, Suatoni P, Brignole C, Perri P, Ponzoni M, Pastorino U, Sozzi G, Fortunato O. Di Paolo D, et al. Among authors: suatoni p. Mol Oncol. 2021 Nov;15(11):2969-2988. doi: 10.1002/1878-0261.13036. Epub 2021 Jul 21. Mol Oncol. 2021. PMID: 34107168 Free PMC article.
Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy.
Apolone G, Montomoli E, Manenti A, Boeri M, Sabia F, Hyseni I, Mazzini L, Martinuzzi D, Cantone L, Milanese G, Sestini S, Suatoni P, Marchianò A, Bollati V, Sozzi G, Pastorino U. Apolone G, et al. Among authors: suatoni p. Tumori. 2021 Oct;107(5):446-451. doi: 10.1177/0300891620974755. Epub 2020 Nov 11. Tumori. 2021. PMID: 33176598 Free PMC article.
25 results